Landscapes / Companies
Biocad not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
8 in Phase 3
Drugs
14
in active trials · 23 in all
Trials
20 active
54 since 2021
Drugs14
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Approved in Russia | — | |||
| How it works | An antibody | ||||
| Also tested for | Rheumatoid Arthritis | ||||
| Open drug page | |||||
Monoclonal antibody |
Approved in Russia | — | |||
| How it works | An antibody | ||||
| Also tested for | Melanoma, Melanoma (Skin) and 5 more | ||||
| Open drug page | |||||
— |
Phase 3 | Jan 2027Phase 3 trial completes | |||
| Next date | Jan 2027 · Phase 3 trial completes | ||||
| Also tested for | Melanoma (Skin), Melanoma Stage III and 5 more | ||||
| Open drug page | |||||
— |
Phase 3 | Jul 2028Phase 3 trial completes | |||
| Next date | Jul 2028 · Phase 3 trial completes | ||||
| Also tested for | Relapsed/Refractory Multiple Myeloma, Myeloma Multiple | ||||
| Open drug page | |||||
— |
Phase 3 | Dec 2028Phase 3 trial completes | |||
| Next date | Dec 2028 · Phase 3 trial completes | ||||
| Also tested for | Relapsing-remitting Multiple Sclerosis (RRMS) | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Anemia, Chronic Kidney Disease and 2 more | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Axial Spondyloarthritis | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Advanced Melanoma, Melanoma (Skin) | ||||
| Open drug page | |||||
Monoclonal antibody |
Phase 3 | — | |||
| How it works | An antibody | ||||
| Also tested for | Systemic Scleroderma, Neuromyelitis Optica Spectrum Disorders and 1 more | ||||
| Open drug page | |||||
— |
Phase 2 | Jan 2027Phase 2 trial completes | |||
| Next date | Jan 2027 · Phase 2 trial completes | ||||
| Also tested for | Crohn's Disease (CD), Ulcerative Colitis (UC) | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Axial Spondyloarthritis | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Triple Negative Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Systemic Lupus Erthematosus | ||||
| Open drug page | |||||
No drugs match “”.
About
- No active trial
- 9 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021